Lung mass epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The following is the epidemiology and demographics of lung mass:<ref name="pmid2244002">{{cite journal |vauthors=Littleton JT, Durizch ML, Moeller G, Herbert DE |title=Pulmonary masses: contrast enhancement |journal=Radiology |volume=177 |issue=3 |pages=861–71 |year=1990 |pmid=2244002 |doi=10.1148/radiology.177.3.2244002 |url=}}</ref> | The following is the epidemiology and demographics of lung mass:<ref name="pmid2244002">{{cite journal |vauthors=Littleton JT, Durizch ML, Moeller G, Herbert DE |title=Pulmonary masses: contrast enhancement |journal=Radiology |volume=177 |issue=3 |pages=861–71 |year=1990 |pmid=2244002 |doi=10.1148/radiology.177.3.2244002 |url=}}</ref><ref name="urlGlobocan 2012 - Home">{{cite web |url=http://globocan.iarc.fr/Default.aspx |title=Globocan 2012 - Home |format= |work= |accessdate=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
*The incidence rate of malignant lung mass is approximately 58 per 100 000 individuals in the United States | *The incidence rate of malignant lung mass is approximately 58 per 100 000 individuals in the United States. | ||
*The incidence rate of lung mass increases with age, tobacco use, and prior cancer | *The incidence rate of lung mass increases with age, tobacco use, and prior cancer. | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of malignancy among lung mass ranges between 0.2% to 50% | *The prevalence of malignancy among lung mass ranges between 0.2% to 50% | ||
| Line 20: | Line 20: | ||
*Males are more commonly affected with lung mass than females. The male to female ratio is approximately 2 to 1. | *Males are more commonly affected with lung mass than females. The male to female ratio is approximately 2 to 1. | ||
===Ethnicity=== | ===Ethnicity=== | ||
*There is no racial predilection of lung mass | *There is no racial predilection of lung mass. | ||
===Case Mortality Rate=== | ===Case Mortality Rate=== | ||
*Lung cancer is the leading cause of cancer related death worldwide. | *Lung cancer is the leading cause of cancer related death worldwide. | ||
Revision as of 17:02, 6 March 2018
|
Lung Mass Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Lung mass epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Lung mass epidemiology and demographics |
|
Risk calculators and risk factors for Lung mass epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
The incidence rate of lung masses is approximately 58 per 100 000 individuals in the United States. The incidence of lung masses increases with age; the median age at diagnosis is between 25 to 70 years. Males are more commonly affected with lung masses than females. The male to female ratio is approximately 2 to 1. There is no racial predilection for lung masses.
Epidemiology and Demographics
The following is the epidemiology and demographics of lung mass:[1][2]
Incidence
- The incidence rate of malignant lung mass is approximately 58 per 100 000 individuals in the United States.
- The incidence rate of lung mass increases with age, tobacco use, and prior cancer.
Prevalence
- The prevalence of malignancy among lung mass ranges between 0.2% to 50%
Age
- The median age at diagnosis for malignant lung mass is between 55 to 70 years.
- The median age at diagnosis for benign lung mass is between 20 to 50 years.
Gender
- Males are more commonly affected with lung mass than females. The male to female ratio is approximately 2 to 1.
Ethnicity
- There is no racial predilection of lung mass.
Case Mortality Rate
- Lung cancer is the leading cause of cancer related death worldwide.
- It has been estimated that lung cancer accounts for approximately 1.5 million deaths annually.
- Amongst men, lung is the most common site for cancer while it is the third most common site in females.
References
- ↑ Littleton JT, Durizch ML, Moeller G, Herbert DE (1990). "Pulmonary masses: contrast enhancement". Radiology. 177 (3): 861–71. doi:10.1148/radiology.177.3.2244002. PMID 2244002.
- ↑ "Globocan 2012 - Home".